1. Home
  2. Analysis
  3. Firazyr
  4. Ms-contin

Firazyr and Ms contin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Firazyr (icatibant acetate) and Ms contin (morphine sulfate). Common drug interactions include colitis among females.

The phase IV clinical study analyzes what interactions people have when they take Firazyr and Ms contin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Firazyr?

Firazyr has active ingredients of icatibant acetate. eHealthMe is studying from 5,650 Firazyr users. Check the latest studies of Firazyr.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.

On Jul, 06, 2026

11 people who take Firazyr and Ms contin together, and have interactions are studied.

Firazyr and Ms contin drug interactions.

What are the common drug interactions of Firazyr and Ms Contin, by gender? *:

female:

  1. Colitis (inflammation of colon)
  2. Hereditary angioedema (recurrent episodes of severe swelling)
  3. Injection site rash
  4. Irritable bowel syndrome
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Renal disorder (kidney disease)
  7. Vertigo
  8. Blood pressure increased
  9. Heart rate decreased
  10. Injection site pain

male:

n/a

What are the common drug interactions of Firazyr and Ms Contin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Bed bug infestation
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Irritable bowel syndrome
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Renal disorder (kidney disease)
  6. Sinusitis (inflammation of sinus)
  7. Vertigo
  8. Blood pressure increased
  9. Heart rate decreased
  10. Injection site pain

60+:

n/a

What are the existing conditions these people have? *

  1. Immune System Disorder: 8 people, 72.73%
  2. Hereditary Angioedema (recurrent episodes of severe swelling): 3 people, 27.27%
  3. Birth Control: 2 people, 18.18%
  4. Myelitis Transverse (a neurological condition consisting of an inflammatory process of the spinal cord): 1 person, 9.09%
  5. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 1 person, 9.09%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 9.09%
  8. Constipation: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Firazyr and Ms contin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Firazyr and Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Firazyr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Firazyr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ms contin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on icatibant acetate and morphine sulfate (the active ingredients of Firazyr and Ms contin, respectively), and Firazyr and Ms contin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.